Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes

2015 ◽  
Vol 87 (2) ◽  
pp. 200-208 ◽  
Author(s):  
Alexandre Benjo ◽  
Rhanderson N. Cardoso ◽  
Tyrone Collins ◽  
Daniel Garcia ◽  
Francisco Y. Macedo ◽  
...  
Keyword(s):  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Vascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

scholarly journals TCT-661 Vascular Brachytherapy versus Drug-Eluting Stents in the Treatment of In-Stent Restenosis: a Meta-Analysis of Long Term Outcomes

2014 ◽  
Vol 64 (11) ◽  
pp. B192-B193
Author(s):  
Rhanderson N. Cardoso ◽  
Alexandre M. Benjo ◽  
Tyrone Collins ◽  
Daniel Garcia ◽  
Francisco Y. Macedo ◽  
...  
Keyword(s):  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Vascular Brachytherapy ◽  
Drug Eluting ◽  
In Stent Restenosis

scholarly journals Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice

2011 ◽  
Vol 6 (6) ◽  
pp. 748-753 ◽  
Author(s):  
Clare Appleby ◽  
Raj Khattar ◽  
Kenneth Morgan ◽  
Bernard Clarke ◽  
Nicholas Curzen ◽  
...  
Keyword(s):  
Real World ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Long Term Outcomes ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis

scholarly journals Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis

2018 ◽  
Vol 2018 ◽  
pp. 1-14 ◽  
Author(s):  
Wen-Juan Xiu ◽  
Hai-Tao Yang ◽  
Ying-Ying Zheng ◽  
Yi-Tong Ma ◽  
Xiang Xie
Keyword(s):  
Observational Studies ◽  
Second Generation ◽  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Randomized Controlled ◽  
Stent Restenosis ◽  
Significant Difference ◽  
Drug Eluting ◽  
In Stent Restenosis

Background. In-stent restenosis (ISR) remains a common problem following percutaneous coronary intervention (PCI). However, the best treatment strategy remains uncertain. There is some controversy over the efficacy of drug-eluting balloons (DEBs) and second-generation drug-eluting stents (DESs) for treating ISR. Methods. A meta-analysis was used to compare the efficacy of the DEB and second-generation DES in the treatment of ISR. The primary endpoint is the incidence of target lesion revascularization (TLR). The secondary endpoint is the occurrence of target vessel revascularization (TVR), myocardial infarction (MI), all-cause death (ACM), cardiac death (CD), major adverse cardiac events (MACEs), minimum luminal diameter (MLD), late luminal loss (LLL), binary restenosis (BR), and percent diameter stenosis (DS%). Results. A total of 12 studies (4 randomized controlled trials and 8 observational studies) including 2020 patients with a follow-up of 6–25 months were included in the present study. There was a significant difference in the MLD between the two groups during follow-up (P=0.007, RR = 0.23, and 95% CI: 0.06–0.4 mm). There was no significant difference in LLL, BR, or DS% and the overall incidence of MACEs between the two groups. Subgroup analysis showed no significant difference in the incidence of primary and secondary endpoints when considering RCTs or observational studies only. Conclusions. The efficacy of the DEB and second-generation DES in the treatment of ISR is comparable. However, our results need further verification through multicenter randomized controlled trials.

scholarly journals TCT-705 Current treatment strategies for in-stent restenosis in the era of drug eluting stents: A Meta-analysis

2018 ◽  
Vol 72 (13) ◽  
pp. B282
Author(s):  
Haroon Kamran ◽  
Kleanthis Theodoropoulos ◽  
Carla Saladini ◽  
Jonathan Marmur ◽  
Giulio Stefanini
Keyword(s):  
Meta Analysis ◽  
Treatment Strategies ◽  
Current Treatment ◽  
Drug Eluting Stents ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis
Sign in / Sign up

Export Citation Format

Share Document